The Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 17.6 pts more than Nifty Microcap 250 and 18.0 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited's Board approved audited FY2026 results showing total income of Rs 28,971 lakhs with PAT of Rs 1,443 lakhs, compared to a loss in the prior year. The auditors (Kalyaniwalla & Mistry LLP) issued an unmodified opinion. The Board recommended a final dividend of Rs 7 per equity share (70%) for FY2026, subject to shareholder approval. In a KMP change, Mr. Amit Goriwale stepped down as Interim CFO & CRO effective May 31, 2026, and Mr. Chirag Kothari, a qualified Chartered Accountant with over 20 years of experience (previously with Wadia Group), was appointed as the new CFO & CRO effective June 1, 2026. Goriwale will remain with the company as Deputy Manager.
The CFO transition is smooth with a ready replacement, reducing execution risk. Strong FY2026 profitability recovery and the dividend recommendation are positive signals for shareholders. The appointment of an experienced external CFO may bring stronger financial controls.